|
業務類別
|
Medical Devices |
|
業務概覽
|
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets. |
| 公司地址
| Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF |
| 電話號碼
| +44 1534756700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.novocure.com |
| 員工數量
| 1605 |
| Mr. Michael Puri |
Chief Human Resources Officer |
-- |
26/02/2026 |
| Dr. Uri Weinberg, M.D.,PhD |
Chief Medical Officer and Chief Innovation Officer |
美元 471.48K |
26/02/2026 |
| Mr. Barak Ben-Arye |
General Counsel |
美元 458.97K |
26/02/2026 |
| Mr. Francis Leonard |
President; Chief Executive Officer of the Company and Subsidiary |
美元 525.00K |
26/02/2026 |
| Mr. Christoph Brackmann |
Chief Financial Officer and Principal Accounting Officer |
-- |
26/02/2026 |
| Mr. Mukund Paravasthu |
Chief Operating Officer |
-- |
26/02/2026 |
|
|
| Mr. Martin J. Madden |
Independent Director |
26/02/2026 |
| Mr. William F. Doyle |
Executive Chairman of the Board |
26/02/2026 |
| Mr. Timothy John Scannell |
Independent Director |
26/02/2026 |
| Dr. David T. Hung,M.D. |
Independent Director |
26/02/2026 |
| Ms. Kristin Stafford, C.P.A. |
Independent Director |
26/02/2026 |
| Dr. Allyson J. Ocean, M.D. |
Independent Director |
26/02/2026 |
| Ms. Jeryl L. Hilleman |
Independent Director |
26/02/2026 |
| Mr. William A. Vernon |
Lead Independent Director |
26/02/2026 |
| Mr. Asaf Danziger |
Director |
26/02/2026 |
| Mr. Kinyip Gabriel Leung |
Independent Director |
26/02/2026 |
|
|
|
|
